BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• United States

  Ohio

  July 3, 2024
• United States

  New Hampshire

  July 3, 2024
• United States

  South Dakota

  July 3, 2024
• United States

  Vermont

  July 3, 2024
• United States

  Puerto Rico

  July 3, 2024
• Story type

  Partnered

  July 3, 2024
• United States

  Oregon

  July 3, 2024
• 

  Scrutiny of WuXi Raises Potential Opportunities for Indian CDMOs

  As congressional pressure increases on WuXi AppTec and other China-based companies over alleged ties to the Chinese government, India’s contract development and manufacturing organization sector could benefit.

  July 3, 2024

   · 

  4 min read

   · 

  Tyler Patchen
• 

  Drug Pricing

  Biden, Sanders Call on Novo Nordisk and Eli Lilly to Lower Weight-Loss Drug Prices

  President Joe Biden and Sen. Bernie Sanders in a Tuesday op-ed in USA Today called on Novo Nordisk and Eli Lilly to “stop ripping off Americans” with “unconscionably high prices” for their GLP-1 medicines.

  July 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  J&J, Legend’s Phase III Win Cements Carvykti as Earlier-Line Multiple Myeloma Treatment

  Johnson & Johnson and Legend Biotech’s Carvykti cell therapy significantly improved survival in patients with multiple myeloma when used in the second-line setting, the companies announced on Tuesday.

  July 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac